Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers

BACKGROUND: Hemoglobin A1c is the main treatment target for patients with type 2 diabetes. It has also been shown recently that postprandial glucose and daily glucose fluctuations affect the progression of diabetic complications and atherosclerotic damages. METHODS: Continuous glucose monitoring was...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Masahiro, Hasegawa, Goji, Majima, Saori, Mitsuhashi, Kazuteru, Fukuda, Takuya, Iwase, Hiroya, Kadono, Mayuko, Asano, Mai, Senmaru, Takafumi, Tanaka, Muhei, Fukui, Michiaki, Nakamura, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026053/
https://www.ncbi.nlm.nih.gov/pubmed/24843385
http://dx.doi.org/10.1186/1758-5996-6-54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026053/
https://www.ncbi.nlm.nih.gov/pubmed/24843385
http://dx.doi.org/10.1186/1758-5996-6-54

Ejemplares similares